Pharma major Lupin will be announcing its quarterly results on Wednesday.
Last quarter the key disappointment for Lupin was the margins which came in below expectations. This quarter too is expected to be a little subdued .Here is what one should expect from the company today:
- Margins are expected to be around 14-15 percent.
- Revenue is expected to be flat because the US market continues to be under pressure due to competition in key drugs.
- India business is likely to be impacted because of high base on account of goods and services tax (GST) restocking that took place last year.
- Overall, subdued set of numbers expected.